Market Capitalization of Parmax Pharma (PARMAX)
As of Sept. 15, 2026, Parmax Pharma (PARMAX) market capitalisation is ₹45.61 Cr ($5.07M), with 33.77 L shares outstanding at a current price of ₹135.05 on BSE, ranking 3779 out of 5367 companies by market cap in our screener. Parmax Pharma operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Parmax Pharma share price chart.
Market Cap History of Parmax Pharma (Last 10 Years)
PARMAX market capitalisation from year-end BSE closing prices over the last 10 years. Explore Parmax Pharma intrinsic worth to estimate fundamental worth using multiple valuation models.
End of Year Market Cap History — Parmax Pharma
PARMAX year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. View PARMAX annual price range for the annual high/low range and current price position.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹45.61 Cr
$5.07M USD
|
₹135.05 | BSE | +299.20% |
| 2025 |
₹11.43 Cr
$1.27M USD
|
₹33.83 | BSE | -23.55% |
| 2024 |
₹14.94 Cr
$1.66M USD
|
₹44.25 | BSE | +35.86% |
| 2023 |
₹11.00 Cr
$1.22M USD
|
₹32.57 | BSE | -15.84% |
| 2022 |
₹13.07 Cr
$1.45M USD
|
₹38.70 | BSE | -35.45% |
| 2021 |
₹20.25 Cr
$2.25M USD
|
₹59.95 | BSE | +103.22% |
| 2020 |
₹9.96 Cr
$1.11M USD
|
₹29.50 | BSE | +63.89% |
| 2019 |
₹6.08 Cr
$675,454 USD
|
₹18.00 | BSE | +4.05% |
| 2018 |
₹5.84 Cr
$649,186 USD
|
₹17.30 | BSE | +1.76% |
| 2017 |
₹5.74 Cr
$637,928 USD
|
₹17.00 | BSE | - |